Wells Fargo’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $174K | Buy |
46,551
+4,662
| +11% | +$17.4K | ﹤0.01% | 4464 |
|
|
2025
Q1 | $116K | Buy |
41,889
+923
| +2% | +$2.55K | ﹤0.01% | 4588 |
|
|
2024
Q4 | $227K | Buy |
40,966
+14,846
| +57% | +$82.2K | ﹤0.01% | 4243 |
|
|
2024
Q3 | $218K | Buy |
26,120
+1,039
| +4% | +$8.67K | ﹤0.01% | 4128 |
|
|
2024
Q2 | $171K | Buy |
25,081
+11,024
| +78% | +$75.1K | ﹤0.01% | 4265 |
|
|
2024
Q1 | $92.2K | Buy |
14,057
+2,003
| +17% | +$13.1K | ﹤0.01% | 4567 |
|
|
2023
Q4 | $78.2K | Buy |
12,054
+2,568
| +27% | +$16.7K | ﹤0.01% | 4641 |
|
|
2023
Q3 | $47.7K | Sell |
9,486
-7,827
| -45% | -$39.4K | ﹤0.01% | 4854 |
|
|
2023
Q2 | $151K | Buy |
17,313
+17,104
| +8,184% | +$150K | ﹤0.01% | 4504 |
|
|
2023
Q1 | $2.48K | Buy |
209
+83
| +66% | +$983 | ﹤0.01% | 5872 |
|
|
2022
Q4 | $1.28K | Buy |
126
+4
| +3% | +$41 | ﹤0.01% | 5785 |
|
|
2022
Q3 | $1K | Buy |
122
+70
| +135% | +$574 | ﹤0.01% | 6139 |
|
|
2022
Q2 | $0 | Sell |
52
-561
| -92% | – | ﹤0.01% | 7145 |
|
|
2022
Q1 | $2K | Sell |
613
-4,866
| -89% | -$15.9K | ﹤0.01% | 6348 |
|
|
2021
Q4 | $39K | Buy |
5,479
+5,464
| +36,427% | +$38.9K | ﹤0.01% | 5613 |
|
|
2021
Q3 | $0 | Buy |
+15
| New | – | ﹤0.01% | 7127 |
|
|
2021
Q2 | – | Sell |
-2,714
| Closed | -$60K | – | 7013 |
|
|
2021
Q1 | $60K | Buy |
+2,714
| New | +$60K | ﹤0.01% | 5387 |
|